Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕Baroda BNP Paribas Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundBaroda BNP Paribas Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataBaroda BNP
NAV₹40.2296₹18.0677
NAV date20 Nov 202620 Nov 2026
History10.9 years5.2 years
Expense ratio1.1%1.1%
Stars★★★★★★★★★★
Growth Score67.5048.00

Returns

Tata India Pharma & Healthcare FundBaroda BNP Paribas Business Cycle Fund
1 month+9.87%+9.18%
3 months+1.12%+3.13%
6 months+7.63%+8.62%
YTD+13.73%+5.48%
1 year+11.82%+5.68%
3 years (CAGR)+18.74%+13.61%
5 years (CAGR)+16.00%+12.45%
10 years (CAGR)+15.95%—
Since launch+13.58%+12.09%

Risk

Tata India Pharma & Healthcare FundBaroda BNP Paribas Business Cycle Fund
Volatility15.7%16.4%
Downside volatility10.0%11.0%
Sharpe0.780.43
Sortino1.230.65
Calmar1.120.67
Return / risk1.190.83
Deepest fall−19.84%−20.27%
Days to recover375621
Below its high+0.00%+0.00%

Against benchmark

Tata India Pharma & Healthcare FundBaroda BNP Paribas Business Cycle Fund
Alpha−2.76%+1.67%
Beta1.001.00
R²90.2%96.0%
Up capture91.7%107.1%
Down capture101.4%101.3%
Tracking error4.9%3.3%
Information ratio−0.570.50
Treynor0.110.06

Consistency

Tata India Pharma & Healthcare FundBaroda BNP Paribas Business Cycle Fund
Best 1-year+76.35%+51.92%
Middle 1-year+8.85%+7.52%
Worst 1-year−17.32%−9.50%
1-year periods with a loss29.0%14.8%
Middle 3-year+21.13%+17.11%
Positive months63.9%63.9%
Best day+3.34%+3.55%
Worst day−3.09%−6.39%
Worst 5% day−1.35%−1.42%
Positive days55.4%56.4%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundBaroda BNP Paribas Business Cycle Fund
5-year XIRR+18.07%+12.89%
5-year value₹9,50,065₹8,34,504
3-year XIRR+13.31%+8.40%
1-year XIRR+18.41%+13.44%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth